一个住院患者的急性阿片类药物戒断用胺治疗:一个病例报告
Nicholaus J Christian1, Jenna L Butner, Mariah S Evarts
1From the Department of Internal Medicine, Program in Addiction Medicine, Yale School of Medicine, New Haven, CT (NJC, JLB, MBW); VA Connecticut Healthcare System, West Haven, CT (NJC); Yale New Haven Hospital (MSE); and Chronic Disease Epidemiology Department, Yale School of Public Health (MBW), New Haven, CT.
Journal of addiction medicine
|August 14, 2023
概括
本案例报告详细介绍了一名住院患者成功治疗胺类药物急性阿片类药物戒断 (POW) 的情况. 胺,与布普伦诺芬-纳洛结合,有效地解决了POW严重症状,为阿片类药物使用障碍管理提供了一种新方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
- 成精神病学成精神病学
背景情况:
- 芬太尼在非法药物供应中越来越普遍,因此需要针对急性阿片类药物戒断 (POW) 进行有效的治疗.
- 对于阿片类药物使用障碍 (OUD) 的布普伦诺芬治疗的开始因战俘的风险而复杂化.
- 关于战俘管理的证据有限,影响临床信心和患者获得必要的OUD药物.
研究的目的:
- 报告在住院治疗中首次使用胺类药物治疗急性阿片类药物戒断的病例.
- 评估胺注射在治疗严重战俘中的有效性.
- 探索胺作为阿片类药物使用障碍的辅助治疗的潜力.
主要方法:
- 一名患有严重阿片类药物使用障碍的患者在使用芬太尼后经历POW后,接受了胺输液和布普伦诺芬-纳洛治疗.
- 患者在24小时内接受了两剂胺输液.
- 监测临床阿片类戒断量表 (COWS) 评分,以评估治疗反应.
主要成果:
- 最初的布普伦诺芬-纳洛给药使POW症状恶化,CowS得分显著增加.
- 胺注入导致战俘症状显著改善,降低了COWS分数.
- 在第二次胺注射后,POW症状完全消失,使患者在布普伦诺芬-纳洛上稳定和出院.
结论:
- 胺作为住院患者急性阿片类药物戒断的治疗方法具有前景.
- 这一案例证明了在住院治疗中使用氨酸用于战俘管理的可行性.
- 需要进一步的研究来确定胺在治疗阿片类药物使用障碍中的有效性和作用.
相关概念视频
01:24Parenteral Anesthetics: Overview
155
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
155
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
335
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
335
01:14CNS Depressants: Barbiturates and Benzodiazepines
322
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
322
01:19Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202
01:26Psychosis: Goals of Pharmacotherapy
166
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
166